TY - JOUR
T1 - Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model
T2 - iBRN
AU - Nogami, Masahiro
AU - Ishikawa, Mitsuru
AU - Doi, Atsushi
AU - Sano, Osamu
AU - Sone, Takefumi
AU - Akiyama, Tetsuya
AU - Aoki, Masashi
AU - Nakanishi, Atsushi
AU - Ogi, Kazuhiro
AU - Yano, Masato
AU - Okano, Hideyuki
N1 - Funding Information:
This work was supported by grants from the SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan , and the MEXT Grant-in-Aid , Japan (grant no. JP20H00485 ) (to M. Y. and H. O.) and partly supported by the Japan Agency for Medical Research and Development (AMED) (The Acceleration Program for Intractable Disease Research Utilizing Disease-specific iPS Cells to H.O. (Grant No. JP19bm0804003 , JP20bm0804003 and JP21bm0804003 ), the Research on Practical Application of Innovative Pharmaceutical and Medical Devices for Rare and Intractable Diseases to H.O. (Grant No. JP 18ek0109395h0001 , 19ek0109395h0002 )).
Publisher Copyright:
© 2021 The Author(s)
PY - 2021/7
Y1 - 2021/7
N2 - Fused in sarcoma/translated in liposarcoma (FUS) is a causative gene of amyotrophic lateral sclerosis (ALS). Mutated FUS causes accumulation of DNA damage and cytosolic stress granule (SG) formation, thereby motor neuron (MN) death. However, key molecular aetiology remains unclear. Here, we applied a novel platform technology, iBRN, “Non- biased” Bayesian gene regulatory network analysis based on induced pluripotent stem cell (iPSC)-derived cell model, to elucidate the molecular aetiology using transcriptome of iPSC-derived MNs harboring FUSH517D. iBRN revealed “hub molecules”, which strongly influenced transcriptome network, such as miR-125b-5p-TIMELESS axis and PRKDC for the molecular aetiology. Next, we confirmed miR-125b-5p-TIMELESS axis in FUS H517D MNs such that miR-125b-5p regulated several DNA repair-related genes including TIMELESS. In addition, we validated both introduction of miR-125b-5p and knocking down of TIMELESS caused DNA damage in the cell culture model. Furthermore, PRKDC was strongly associated with FUS mis-localization into SGs by DNA damage under impaired DNA-PK activity. Collectively, our iBRN strategy provides the first compelling evidence to elucidate molecular aetiology in neurodegenerative diseases.
AB - Fused in sarcoma/translated in liposarcoma (FUS) is a causative gene of amyotrophic lateral sclerosis (ALS). Mutated FUS causes accumulation of DNA damage and cytosolic stress granule (SG) formation, thereby motor neuron (MN) death. However, key molecular aetiology remains unclear. Here, we applied a novel platform technology, iBRN, “Non- biased” Bayesian gene regulatory network analysis based on induced pluripotent stem cell (iPSC)-derived cell model, to elucidate the molecular aetiology using transcriptome of iPSC-derived MNs harboring FUSH517D. iBRN revealed “hub molecules”, which strongly influenced transcriptome network, such as miR-125b-5p-TIMELESS axis and PRKDC for the molecular aetiology. Next, we confirmed miR-125b-5p-TIMELESS axis in FUS H517D MNs such that miR-125b-5p regulated several DNA repair-related genes including TIMELESS. In addition, we validated both introduction of miR-125b-5p and knocking down of TIMELESS caused DNA damage in the cell culture model. Furthermore, PRKDC was strongly associated with FUS mis-localization into SGs by DNA damage under impaired DNA-PK activity. Collectively, our iBRN strategy provides the first compelling evidence to elucidate molecular aetiology in neurodegenerative diseases.
KW - Amyotrophic lateral sclerosis (ALS)
KW - Bayesian gene regulatory network analysis based on iPSC-derived cell model (iBRN)
KW - DNA damage response (DDR)
KW - Fused in sarcoma/translated in liposarcoma (FUS)
KW - Induced pluripotent stem cell
UR - http://www.scopus.com/inward/record.url?scp=85105552966&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105552966&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2021.105364
DO - 10.1016/j.nbd.2021.105364
M3 - Article
C2 - 33857636
AN - SCOPUS:85105552966
SN - 0969-9961
VL - 155
JO - Neurobiology of Disease
JF - Neurobiology of Disease
M1 - 105364
ER -